Celltrion opens production site in New Jersey

Celltrion officially launched the operation of its new production facility in Branchburg, New Jersey, Monday (local time), just five months after the Korean biotech firm took over the facility from Eli Lilly to expand its U.S. presence. Celltrion Chairman Seo Jung-jin, U.S. Senator Andy Kim, Rep. Thomas Kean Jr., Branchburg Township Mayor Thomas Young and other dignitaries attended the opening ceremony, where Kean presented a U.S. flag and asked that it be displayed at the facility. “We will expand the Branchburg facility into an integrated contract development and manufacturing hub by setting up R&D centers,” Seo said during the ceremony. “This will make Celltrion Branchburg one of the key pillars of Celltrion’s global growth alongside our headquarters in Songdo (Incheon).” The company also appointed Todd Winge, former site head of Eli Lilly’s Branchburg operations, as CEO of Celltrion Branchburg, establishing a locally based management system. The launch came just five months after Celltrion was selected as the preferred bidder for the Branchburg facility in late July. CellWeiter zum vollständigen Artikel bei Korea Times Weiter zum vollständigen Artikel bei Korea Times